Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18762903 | 0.80 | NOTUM (0.38) | CES1TYMSCXCR2MAPTNOTUM | |
| SCHEMBL18762944 | 0.79 | ALDH1A1 (0.38) | TYMSMAPT | |
| SCHEMBL18762964 | 0.66 | — | — | |
| SCHEMBL30006698 | 0.66 | GPR3 (0.48) | CES1MAPT | |
| SCHEMBL111049 | 0.66 | GPR3 (0.48) | CES1MAPT | |
| SCHEMBL18762941 | 0.65 | MAOA (0.42) | MAPT | |
| SCHEMBL18762933 | 0.64 | BRD4 (0.31) | — | |
| SCHEMBL11215187 | 0.64 | ALDH1A1 (0.42) | — | |
| SCHEMBL18762958 | 0.64 | — | — | |
| SCHEMBL11425782 | 0.63 | S100A4 (0.49) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12255288-B2 | Nonaqueous electrolytic solution for battery and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2025-03-18 | — | — | US | disclosed |
| US-12095037-B2 | Non-aqueous electrolyte solution for battery and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20220158247-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2022-05-19 | — | — | US | disclosed |
| EP-3951950-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES, AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-113646931-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2021-11-12 | — | — | CN | disclosed |
| US-20210296703-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERY AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2021-09-23 | — | — | US | disclosed |
| EP-3828981-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2021-06-02 | — | — | EP | disclosed |
| CN-112470320-A | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2021-03-09 | — | — | CN | disclosed |
| US-10290900-B2 | Non-aqueous electrolytic solution and lithium ion secondary battery comprising same | NIPPON SHOKUBAI CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170117582-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM ION SECONDARY BATTERY COMPRISING SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 2017-04-27 | — | — | US | disclosed |
| US-7432058-B2 | Methods of labeling nucleic acids with energy transfer dyes | APPLERA CORPORATION (US) | 2008-10-07 | — | — | US | disclosed |
| US-7388092-B2 | Oligonucleotides and analogs labeled with energy transfer dyes | APPLERA CORPORATION (US) | 2008-06-17 | — | — | US | disclosed |
| US-20070161027-A1 | OLIGONUCLEOTIDES AND ANALOGS LABELED WITH ENERGY TRANSFER DYES | APPLERA CORPORATION (US) | 2007-07-12 | — | — | US | disclosed |
| US-6335440-B1 | NUCLEIC ACID SEQUENCING | PE CORPORATION (NY) | 2002-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161027-A1 | OLIGONUCLEOTIDES AND ANALOGS LABELED WITH ENERGY TRANSFER DYES | RBM28, TRDMT1, RTCB | CES1 1901/4885TYMS 266/4885CXCR2 2307/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.